Myanmar is better known for its serious drug problems - including large-scale illicit drugs production and trafficking and high rates of heroin use - than for implementing progressive drug policies that prioritise the health of its population. However, this could change in the near future.
The recently-released “Myanmar Opium Survey 2018” by the United Nations Office on Drugs and Crime (UNODC) entails specific accusations against several of the conflict actors. This commentary explains how this further distorts, rather than reflects, the complex realities in Myanmar.
The problem of opium should not be perceived only as a simple, black-and-white, law enforcement problem. To address problems related to opium cultivation, substantial socio-economic development is required to provide meaningful alternatives for farmers, and to ensure that a humanitarian crisis will not occur as the consequence of repressive drug control policies.
The recent publication of two single pieces of legislation - the amended 1993 Narcotic Drugs and Psychotropic Substances Law and the first National Drug Control Policy - is likely to form the basis of Myanmar’s drug policy for several years to come. What does it mean for the country’s transition towards an evidence-based approach to drug control, and how can the gaps between the two documents be addressed?
In Myanmar’s Kachin State, a women’s drop-in centre has transformed into more than just a harm reduction facility. Leading up to International Women’s Day, we spoke with Thinzar Tun (AHRN Myanmar) about what makes this centre special.